Machine Learning

A new survey shows 94% of manufacturers now use AI, but tech investment is a defensive strategy against economic, trade, and workforce pressures.

Amid a 257% SSD price surge and year-long lead times, VDURA launches a program to beat top all-flash systems by 50%, betting on mixed-storage tech.

A new partnership marries AI design with high-throughput lab validation, creating a blueprint to accelerate the creation of new medicines.

With $10M from tech and sports titans, Curate uses Apple App Clips and AI to help restaurants bypass costly delivery fees and win back their customers.

With a strategic investment from Headline Asia, Zettabyte aims to solve Japan's AI power crunch using its advanced software to optimize GPU performance.

A new partnership integrates whole-genome sequencing into a clinical trial for a novel cancer drug, promising to accelerate development and usher in a new era.

Fintech firm Credibly has patented a Generative AI platform, promising faster, fairer capital access for SMBs and challenging traditional lending models.

As its promising prostate cancer drug nears Phase 3, Convergent Therapeutics hires a new CPO to build the team for its next critical growth phase.

Enveric Biosciences raises $1.5M to advance its novel psychiatric drugs. Is this small cash infusion enough to propel its promising pipeline forward?

Drowning in cryptic APIs? Salt Security's new AI instantly explains what any API does, bridging the skills gap and accelerating threat detection.

BioBridges and its legacy brands consolidate into Peritia, a new end-to-end platform designed to accelerate product development for resource-strapped teams.

Over 60% of cats and 59% of dogs are overweight, a silent crisis shortening lives. Vets warn against risky shortcuts and urge proactive, guided care.

A new grant funds a radical approach using AI and postmortem human brains to find crucial clues for Parkinson's therapies, aiming to crack a major medical challenge.

Dr. Marinna Madrid's new role at Cellino signals a new era for AI in medicine, as she builds both the tech and the regulatory roadmap for personalized therapies.

A landmark FDA decision allows Life Biosciences to test its epigenetic reprogramming therapy, ER-100, offering new hope for restoring sight in the blind.

BlueParrott's new M500-XT headset uses advanced AI to eliminate 93% of background noise, offering unparalleled clarity for drivers and gig workers.

A new SoHo wellness hub uses invisible tech and EEG sensors to read your mind and adapt its environment. But is this the future or a privacy nightmare?

A new university study finds students love AI learning tools but have major concerns, offering a global roadmap for ethical and equitable integration.

With promising brain scan data, a deep therapeutic pipeline, and a cash runway into 2027, Radiopharm Theranostics is gaining significant momentum.

Singapore's Vocalbeats.AI sees its Owll and Owll Translator apps hit top grossing spots worldwide, challenging tech giants and redefining productivity.